Results 31 to 40 of about 14,159 (238)
Kidney Research and Clinical Practice, 2020 Background : We report the findings of a single Italian center in the evaluation of renal lesions in deceased donors from 2001 to 2017. In risk evaluation, we applied the current Italian guidelines, which include donors with small (< 4 cm, stage pT1a ...
Francesca Ambrosi +8 more
doaj +1 more source
Cytologic analysis of papillary renal cell carcinoma [PDF]
Cancer, 1998 The papillary variant of renal cell carcinoma has distinctive pathologic and clinical features. Because the prognosis of patients with papillary renal cell carcinoma differs from that of patients with other variants of renal cell carcinoma, accurate diagnosis based on cytologic material may be important for appropriate clinical disease management.A ...
Scott R. Granter +2 more
openaire +3 more sources
Familial Follicular-Cell Derived Carcinoma
Frontiers in Endocrinology, 2012 Follicular cell-derived well-differentiated thyroid cancer, papillary (PTC) and follicular thyroid carcinomas (FTC) compose 95% of all thyroid malignancies.
Eun Ju eSon, Vania eNosé
doaj +1 more source
Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature
Frontiers in Oncology, 2023 Papillary renal neoplasm with reverse polarity (PRNRP) is a rare renal tumour and was newly named in 2019. This study reported a case of a 30-year-old female patient with a left renal tumour without any clinical symptoms and whose CT scan of her left ...
Xi Tu +4 more
doaj +1 more source
PRCC (papillary renal cell carcinoma) [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Review on PRCC (papillary renal cell carcinoma), with data on DNA, on the protein encoded, and where the gene is implicated.
F Desangles, Jean-Loup Huret
openaire +2 more sources
An Update on the Treatment of Papillary Renal Cell Carcinoma
Cancers, 2023 Papillary renal cell carcinoma (pRCC) is the second-most common subtype of kidney cancer following clear cell renal cell carcinoma (ccRCC), representing 15% of kidney cancers. Despite advances in therapy, including combination strategies with targeted therapies and immune checkpoint inhibitors, progress has lagged behind that of ccRCC.
Neal S. Chawla +5 more
openaire +2 more sources
Indian Journal of Pathology and Microbiology, 2023 Xp11 translocation renal cell carcinoma (XPTRCC) is a very rare kidney neoplasm, which has been predominantly reported in young patients. Sarcomatoid transformation in renal cell carcinomas is known. However, its occurrence in XPTRCC is unreported so far
Rakhi V. Jagdale +3 more
doaj +1 more source
Expression of nectin-4 in papillary renal cell carcinoma
Discover Oncology, 2022 Abstract Background Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and checkpoint inhibitors are currently treatments of choice.
Zschäbitz, Stefanie +28 more
openaire +5 more sources
Journal of Urological Surgery, 2018 We present a unique case of concurrent chromophobe, clear cell, and papillary renal cell carcinomas (RCC) in three separate sites in the same kidney after partial nephrectomy. We review the literature of synchronous RCC of up to two histologic subtypes,
Joan C. Delto +6 more
doaj +1 more source
EJNMMI Research, 2017 Background Despite the progress in the quality of multiphasic CT and MRI scans, it is still difficult to fully characterize a solid kidney lesion. Approximately 10% of all solid renal tumours turn out to be oncocytomas.
Antonios Tzortzakakis +5 more
doaj +1 more source